Ulteriori informazioni
Previously known as Biennial Review of Infertility, the fifth installment in this series brings together the most current research and clinical evidence on male and female infertility, emerging assisted reproductive technologies (ART) and evolving controversies in reproductive medicine. In this latest volume, parts one and two discuss recent developments in male and female infertility respectively, including fertility preservation in the male adolescent cancer patient, the clinical relevance of sperm RNA, the management of subclinical hypothyroidism, and the effects of endocrine-disrupting chemicals. Part three covers the latest in ART, such as evidence-based morphological approaches for embryo selection and culturing human embryos. The final section highlights controversies in reproductive medicine, including the use of preimplantation genetic screening (PGS) and blastocyst transfer, as well as the ethics surrounding a maximum BMI for IVF.
Providing an ongoing appraisal of current knowledge, and featuring contributions from leading experts in the field, Emerging Topics in Reproduction, Volume 5 is a worthy addition to the series and an ideal resource on the latest topics for reproductive medicine and REI specialists, OB-GYNS, andrologists, and any clinician working with infertility.
Sommario
Part I: Male Infertility.- TESE for Cryptozoospermia with Normal Sperm DNA Fragmentation.- The Argument for Varicocele Repair in Non-Obstructive Azoospermia.- Current and Future Perspectives on Sperm RNAs.- Male Infertility as a Marker of Future Health.- Fertility Preservation in the Male Adolescent Patient.- Part II: Female Infertility.- Advanced Imaging Techniques Used in the Infertile Female.- Treatment of Subclinical Hypothyroidism in the Infertile Female.- Endocrine-Disrupting Chemicals and Female Infertility.- Part III: Assisted Reproductive Technologies.- Is There an Optimum System for Culturing Human Embryos?- Evidence-Based Approaches to Embryo Selection by Morphology and Kinetics.- Part IV: Controversies in Reproductive Medicine.- Is It Good Practice/Ethical to Set a Max BMI Before IVF?- Are We Closer to "Freeze-All" for ART?- Preimplantation Genetic Screening: Not for Everyone.- Should All Patients Undergo Blastocyst Transfer? No.
Info autore
Douglas T. Carrell, PhD, HCLD, Departments of Surgery (Urology) and Human Genetics, Director of IVF, Andrology and Reproductive Research Laboratories, University of Utah School of Medicine, Salt Lake City, UT, USA
Catherine Racowsky, PhD, HCLD, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Peter N. Schlegel, MD, Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA
Alan H. DeCherney, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, USA
Riassunto
Discusses recent breakthroughs and hot topics in the treatment of both male and female infertility, ART and evolving controversies in reproductive medicine
Presents insightful, evidence-based discussion of both common and complex clinical procedures as well as yes/no debate forums
Provides a space for newly developing fields of study as well as broad collaboration between diverse specialties working with infertility
